AI in Healthcare: Insights from Two Decades of FDA Approvals

Oct 06, 2021

Posted by Health Advances LLC

Resurgence in Drug Development for Renal Diseases

Oct 06, 2021

Posted by Health Advances LLC

Japan and China are Outpacing Europe as Leading Biopharmaceutical Innovation Hubs

Oct 06, 2021

Posted by Health Advances LLC

Unlocking Potential Cures with CRISPR: Indication Selection And Portfolio Strategy For CRISPR-Based Gene Editing Companies

Oct 06, 2021

Posted by Health Advances LLC

Executing a Successful Hybrid Certification Training

Oct 04, 2021

BioIVT Enhances its Website to Facilitate Drug and Diagnostic R&D

Oct 04, 2021

Posted by BioIVT

Asymmetrex Awarded Grant from ARMI BioFabUSA to Develop Tissue Stem Cell Counting Technology for Cell Biomanufacturing

Oct 04, 2021

Posted by Asymmetrex, LLC